UPDATE 1-Blues health insurers put up $55 million to take on generic drug makers
January 23, 2020 at 12:13 PM EST
A group of Blue Cross Blue Shield insurers is investing $55 million in a venture that aims to offer cheaper prices to their members on generic drugs that currently have little or no competition, the companies said on Thursday.